Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes

被引:26
作者
Voorham, Jaco [1 ,2 ,3 ]
Denig, Petra [2 ,3 ]
Wolffenbuttel, Bruce H. R. [4 ]
Haaijer-Ruskamp, Flora M. [2 ,3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Hlth Res, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
关键词
quality indicators health care; diabetes mellitus; quality of health care; outcome and process assessment (health care);
D O I
10.1097/MLR.0b013e31815b9da0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The fairness of quality assessment methods is under debate. Quality indicators incorporating the longitudinal nature of care have been advocated but their usefulness in comparison to more commonly used cross-sectional measures is not clear. Aims: To compare cross-sectional and sequential quality indicators for risk factor management in patients with type 2 diabetes. Methods: The study population consisted of 1912 patients who received diabetes care from one of 40 general practitioners in The Netherlands. Clinical outcomes, prescriptions, and demographic data were collected from electronic medical records. Quality was assessed for glycemic, blood pressure, and lipid control using indicators focusing on clinical outcomes, and treatment in relation to outcomes. Indicator results were compared with a reference method based on national guidelines for general practice. Results: According to the reference method, 76% of the patients received management as recommended for glycemic control, 58% for blood pressure control, and 67% for lipid control. Cross-sectional indicators looking at patients adequately controlled gave estimates that were 10-25% lower than the reference method. Estimates from indicators focusing on uncontrolled patients receiving treatment were 10-40% higher than the reference method for blood pressure and glycemic control. Sequential indicators focusing on improvement in clinical outcomes or assessing treatment modifications in response to poor control gave results closer to the reference method. Conclusions: Sequential indicators are valuable for estimating quality of risk factor management in patients with diabetes. Such indicators may provide a more accurate and fair judgment than currently used cross-sectional indicators.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 40 条
[11]   Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics [J].
Duggirala, MK ;
Cuddihy, RM ;
Cuddihy, MT ;
Naessens, JM ;
Cha, SS ;
Mandrekar, JN ;
Leibson, CL .
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (06) :833-838
[12]  
*FARM KOMP, 2004, DUTCH PHARM COMP
[13]   The heart protection study: Expanding the boundaries for high-risk coronary disease prevention [J].
Farmer, JA ;
Gotto, AM .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (1A) :3I-9I
[14]  
Frijling BD, 2001, BRIT J GEN PRACT, V51, P9
[15]   Quality of outpatient care for diabetes mellitus in a national electronic health record network [J].
Gill, JM ;
Foy, AJ ;
Ling, Y .
AMERICAN JOURNAL OF MEDICAL QUALITY, 2006, 21 (01) :13-17
[16]   Quality of diabetes care in US academic medical centers - Low rates of medical regimen change [J].
Grant, RW ;
Buse, JB ;
Meigs, JB .
DIABETES CARE, 2005, 28 (02) :337-342
[17]   Clinical inertia in the management of Type 2 diabetes metabolic risk factors [J].
Grant, RW ;
Cagliero, E ;
Dubey, AK ;
Gildesgame, C ;
Chueh, HC ;
Barry, MJ ;
Singer, DE ;
Nathan, DM ;
Meigs, JB .
DIABETIC MEDICINE, 2004, 21 (02) :150-155
[18]   Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes [J].
Grant, RW ;
Cagliero, E ;
Murphy-Sheehy, P ;
Singer, DE ;
Nathan, DM ;
Meigs, JB .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (08) :603-609
[19]   The quality of pharmacologic care for vulnerable older patients [J].
Higashi, T ;
Shekelle, PG ;
Solomon, DH ;
Knight, EL ;
Roth, C ;
Chang, JT ;
Kamberg, CJ ;
MaClean, CH ;
Young, RT ;
Adams, J ;
Reuben, DB ;
Avorn, J ;
Wenger, NS .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (09) :714-720
[20]  
*IDF CLIN GUID TAS, 2005, GLOB GUID TYPE 2 DIA